These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 19149726)

  • 1. Chitosan and its use in design of insulin delivery system.
    Wong TW
    Recent Pat Drug Deliv Formul; 2009 Jan; 3(1):8-25. PubMed ID: 19149726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of oral insulin delivery systems.
    Wong TW
    J Drug Target; 2010 Feb; 18(2):79-92. PubMed ID: 19968567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nasal delivery of insulin using bioadhesive chitosan gels.
    Varshosaz J; Sadrai H; Heidari A
    Drug Deliv; 2006; 13(1):31-8. PubMed ID: 16401591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption.
    Sheng J; Han L; Qin J; Ru G; Li R; Wu L; Cui D; Yang P; He Y; Wang J
    ACS Appl Mater Interfaces; 2015 Jul; 7(28):15430-41. PubMed ID: 26111015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alginate/chitosan nanoparticles are effective for oral insulin delivery.
    Sarmento B; Ribeiro A; Veiga F; Sampaio P; Neufeld R; Ferreira D
    Pharm Res; 2007 Dec; 24(12):2198-206. PubMed ID: 17577641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral insulin delivery: existing barriers and current counter-strategies.
    Gedawy A; Martinez J; Al-Salami H; Dass CR
    J Pharm Pharmacol; 2018 Feb; 70(2):197-213. PubMed ID: 29193053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advancements in oral administration of insulin-loaded liposomal drug delivery systems for diabetes mellitus.
    Wong CY; Al-Salami H; Dass CR
    Int J Pharm; 2018 Oct; 549(1-2):201-217. PubMed ID: 30071309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chitosan coating of zein-carboxymethylated short-chain amylose nanocomposites improves oral bioavailability of insulin in vitro and in vivo.
    Ji N; Hong Y; Gu Z; Cheng L; Li Z; Li C
    J Control Release; 2019 Nov; 313():1-13. PubMed ID: 31622690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasal absorption and local tissue reaction of insulin nanocomplexes of trimethyl chitosan derivatives in rats.
    Jintapattanakit A; Peungvicha P; Sailasuta A; Kissel T; Junyaprasert VB
    J Pharm Pharmacol; 2010 May; 62(5):583-91. PubMed ID: 20609059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. pH-responsive nanoparticles shelled with chitosan for oral delivery of insulin: from mechanism to therapeutic applications.
    Sung HW; Sonaje K; Liao ZX; Hsu LW; Chuang EY
    Acc Chem Res; 2012 Apr; 45(4):619-29. PubMed ID: 22236133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient mucus permeation and tight junction opening by dissociable "mucus-inert" agent coated trimethyl chitosan nanoparticles for oral insulin delivery.
    Liu M; Zhang J; Zhu X; Shan W; Li L; Zhong J; Zhang Z; Huang Y
    J Control Release; 2016 Jan; 222():67-77. PubMed ID: 26686663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatty acid and quaternary ammonium modified chitosan nanoparticles for insulin delivery.
    Li H; Zhang Z; Bao X; Xu G; Yao P
    Colloids Surf B Biointerfaces; 2018 Oct; 170():136-143. PubMed ID: 29894834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticle strategies for the oral delivery of insulin.
    Damgé C; Reis CP; Maincent P
    Expert Opin Drug Deliv; 2008 Jan; 5(1):45-68. PubMed ID: 18095928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on the insulin-liposomes double-coated by chitosan and chitosan-EDTA conjugates].
    Wu ZH; Ping QN; Song YM; Lei XM; Li JY; Cai P
    Yao Xue Xue Bao; 2004 Nov; 39(11):933-8. PubMed ID: 15696937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eligen insulin--a system for the oral delivery of insulin for diabetes.
    Hoffman A; Qadri B
    IDrugs; 2008 Jun; 11(6):433-41. PubMed ID: 18509785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eudragit S100-Coated Chitosan Nanoparticles Co-loading Tat for Enhanced Oral Colon Absorption of Insulin.
    Chen S; Guo F; Deng T; Zhu S; Liu W; Zhong H; Yu H; Luo R; Deng Z
    AAPS PharmSciTech; 2017 May; 18(4):1277-1287. PubMed ID: 27480441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation of insulin-loaded N-trimethyl chitosan microparticles with improved efficacy for inhalation by supercritical fluid assisted atomization.
    Shen YB; Du Z; Tang C; Guan YX; Yao SJ
    Int J Pharm; 2016 May; 505(1-2):223-33. PubMed ID: 27034000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo evaluation of a nasal insulin delivery system based on thiolated chitosan.
    Krauland AH; Leitner VM; Grabovac V; Bernkop-Schnürch A
    J Pharm Sci; 2006 Nov; 95(11):2463-72. PubMed ID: 16886206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyelectrolyte biomaterial interactions provide nanoparticulate carrier for oral insulin delivery.
    Reis CP; Ribeiro AJ; Veiga F; Neufeld RJ; Damgé C
    Drug Deliv; 2008 Feb; 15(2):127-39. PubMed ID: 18293199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thiolated chitosan microparticles: a vehicle for nasal peptide drug delivery.
    Krauland AH; Guggi D; Bernkop-Schnürch A
    Int J Pharm; 2006 Jan; 307(2):270-7. PubMed ID: 16300914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.